Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide.
Conclusions: The NLR might be a useful biomarker for predicting the prognosis of mCRPC patients who are treated with ENZ.
PMID: 30800682 [PubMed - in process]
Source: Biomed Res - Category: Research Authors: Kumano Y, Hasegawa Y, Kawahara T, Yasui M, Miyoshi Y, Matsubara N, Uemura H Tags: Biomed Res Int Source Type: research
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Prostate Cancer | Radiography | Research | Study | Taxotere